• レポートコード:TPM-2JN074 • 出版社/出版日:Transparency Market Research / 2019年11月26日 • レポート形態:英文、PDF、243ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは光線力学療法の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場状況、市場動向、製品別分析、用途別分析、エンドユーザー別分析、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、次の構成でお届けいたします。 ・序論 ・仮定・研究方法 ・エグゼクティブサマリー ・市場状況 ・市場動向 ・光線力学療法の世界市場:製品別 ・光線力学療法の世界市場:用途別 ・光線力学療法の世界市場:エンドユーザー別 ・光線力学療法の世界市場:地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ) ・光線力学療法の北米市場分析・予測 ・光線力学療法の欧州市場分析・予測 ・光線力学療法のアジア太平洋市場分析・予測 ・光線力学療法の中南米市場分析・予測 ・光線力学療法の中東・アフリカ市場分析・予測 ・競争状況 |
New discoveries in photodynamic therapy (PDT) are benefitting cancer patients. As such, it has been found that, PDT is effective in treating multidrug-resistant breast cancer. Dysfunctional DNA repair genes and abnormal signal transduction are some of the major complications associated with breast cancer resistance. Hence, companies in the photodynamic therapy market are becoming increasingly aware about the complications of breast cancer resistance, and increasing the availability of PDT in hospitals and cancer treatment centers.
Cancer is projected to account for the highest revenue amongst all applications in the photodynamic therapy market, with an estimated value of ~US$ 2.3 billion by the end of 2023. This is why, healthcare companies are increasing awareness about PDT amongst breast cancer resistant patients. As such, PDT is being used as an alternative to broad-spectrum antibiotics-based therapy, thus minimizing the incidence of drug resistance. Companies are also increasing R&D to assess PDT-resistant cells to further study the impact of PDT on cellular targets. Healthcare providers are increasing their efficacy in PDT technology to achieve therapeutic relevance in appropriate photosensitizer (PS) level with its retention in the target tissue.
Growing incidence of actinic keratosis (AK) have led to innovations in the photodynamic therapy market. Dermoscopy serves as a useful tool for monitoring skin lesions during PDT and follow-up. Healthcare providers in the photodynamic therapy landscape are treating actinic keratosis (AK) patients with aminolevulinic acid (ALA) drugs. ALA agents are increasingly gaining popularity, and are anticipated to account for the highest revenue amongst all drugs in the photodynamic therapy market, with a projected value of ~US$ 4 billion by the end of 2027. Thus, healthcare providers in hospitals and dermatology clinics are offering topical ALA-PDT, since the treatment is widely approved by health commissions across various countries.
Dermoscopic monitoring is being used in tandem with PDT, and serves as a valuable and non-invasive technique, not just for diagnosing AK but also other serious skin diseases. The technique of dermoscopy is very useful for healthcare providers, since it can visualize the morphological structures of the inner layers of the skin that are not visible to the naked eye. Thus, dermoscopy is boosting the growth of the photodynamic therapy market.
Healthcare providers in the photodynamic therapy market are adopting new strategies to achieve enhanced clinical translation. They are using the approach of customized protocols for the treatment of cancer and other infectious diseases. Companies are developing improved formulations of porphyrin-derivative (PD) compounds. This trend is projected to grow during the forecast period, since PD is projected to account for the second-highest revenue amongst all drugs in the photodynamic therapy market, with an estimated value of ~US$ 3 billion by the end of 2027. Hence, companies are developing intelligent PD molecules that can target specific cells and offer efficient drug delivery.
Companies in the photodynamic therapy market are developing strategies to improve transdermal ALA delivery. They are utilizing high-power CO2 lasers to produce microhole grating. Companies are increasing the production of ALA creams, since the grating procedure is followed by the application of the cream, assisted by ultrasound, to enhance the cream’s penetration into the holes. Another approach, such as the use of a soluble microneedle patch, helps in continuous delivery of ALA until the material is completely dissolved inside the lesion.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Photodynamic Therapy Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Epidemiology of Skin Disorders and Cancer
5.2. Major Companies in Global Photodynamic Therapy Market
5.3. Regulatory Scenario Assessment
5.4. Technological Advancements
5.5. Major Diseases Treated through Photodynamic Therapy
5.6. Patent Landscape Summary
6. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
6.2.1. Drugs
6.2.1.1. Porphyrin Derivative (PD)
6.2.1.1.1. Hematoporphyrin Derivative (HpD)
6.2.1.1.2. Benzoporphyrin Derivative (BPD)
6.2.1.1.3. Texaphyrins
6.2.1.1.4. Others
6.2.1.2. Aminolevulinic acid (ALA)
6.2.1.3. Chlorines
6.2.1.4. Others
6.2.2. Devices
6.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
6.2.2.2. Diode Laser
6.3. Global Photodynamic Therapy Market Attractiveness, by Product
7. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application
7.1. Introduction
7.2. Global Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
7.2.1. Cancer
7.2.1.1. Basal Cell Carcinoma
7.2.1.2. Non-small Cell Lung Cancer
7.2.1.3. Head & Neck Cancer
7.2.1.4. Others
7.2.2. Actinic Keratosis (AK)
7.2.3. Psoriasis
7.2.4. Acne
7.2.5. Others
7.3. Global Photodynamic Therapy Market Attractiveness, by Application
8. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user
8.1. Introduction
8.2. Global Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
8.2.1. Hospitals
8.2.2. Cosmetics & Dermatology Clinics
8.2.3. Cancer Treatment Centers
8.2.4. Others
8.3. Global Photodynamic Therapy Market Attractiveness, by End-user
9. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region
9.1. Introduction
9.2. Global Photodynamic Therapy Market Value Forecast, by Region, 2017–2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Photodynamic Therapy Market Attractiveness, by Region
10. North America Photodynamic Therapy Market Analysis and Forecast
10.1. Introduction
10.2. North America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
10.2.1. Drugs
10.2.1.1. Porphyrin Derivative (PD)
10.2.1.1.1. Hematoporphyrin Derivative (HpD)
10.2.1.1.2. Benzoporphyrin Derivative (BPD)
10.2.1.1.3. Texaphyrins
10.2.1.1.4. Others
10.2.1.2. Aminolevulinic Acid (ALA)
10.2.1.3. Chlorines
10.2.1.4. Others
10.2.2. Devices
10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
10.2.2.2. Diode Laser
10.3. North America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
10.3.1. Cancer
10.3.1.1. Basal Cell Carcinoma
10.3.1.2. Non-small Cell Lung Cancer
10.3.1.3. Head & Neck Cancer
10.3.1.4. Others
10.3.2. Actinic Keratosis (AK)
10.3.3. Psoriasis
10.3.4. Acne
10.3.5. Others
10.4. North America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Cosmetics & Dermatology Clinics
10.4.3. Cancer Treatment Centers
10.4.4. Others
10.5. North America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Photodynamic Therapy Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Photodynamic Therapy Market Analysis and Forecast
11.1. Introduction
11.2. Europe Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
11.2.1. Drugs
11.2.1.1. Porphyrin Derivative (PD)
11.2.1.1.1. Hematoporphyrin Derivative (HpD)
11.2.1.1.2. Benzoporphyrin Derivative (BPD)
11.2.1.1.3. Texaphyrins
11.2.1.1.4. Others
11.2.1.2. Aminolevulinic Acid (ALA)
11.2.1.3. Chlorines
11.2.1.4. Others
11.2.2. Devices
11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
11.2.2.2. Diode Laser
11.3. Europe Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
11.3.1. Cancer
11.3.1.1. Basal Cell Carcinoma
11.3.1.2. Non-small Cell Lung Cancer
11.3.1.3. Head & Neck Cancer
11.3.1.4. Others
11.3.2. Actinic Keratosis (AK)
11.3.3. Psoriasis
11.3.4. Acne
11.3.5. Others
11.4. Europe Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Cosmetics & Dermatology Clinics
11.4.3. Cancer Treatment Centers
11.4.4. Others
11.5. Europe Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Photodynamic Therapy Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
12.2.1. Drugs
12.2.1.1. Porphyrin Derivative (PD)
12.2.1.1.1. Hematoporphyrin Derivative (HpD)
12.2.1.1.2. Benzoporphyrin Derivative (BPD)
12.2.1.1.3. Texaphyrins
12.2.1.1.4. Others
12.2.1.2. Aminolevulinic Acid (ALA)
12.2.1.3. Chlorines
12.2.1.4. Others
12.2.2. Devices
12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
12.2.2.2. Diode Laser
12.3. Asia Pacific Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
12.3.1. Cancer
12.3.1.1. Basal Cell Carcinoma
12.3.1.2. Non-small Cell Lung Cancer
12.3.1.3. Head & Neck Cancer
12.3.1.4. Others
12.3.2. Actinic Keratosis (AK)
12.3.3. Psoriasis
12.3.4. Acne
12.3.5. Others
12.4. Asia Pacific Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Cosmetics & Dermatology Clinics
12.4.3. Cancer Treatment Centers
12.4.4. Others
12.5. Asia Pacific Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Photodynamic Therapy Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Photodynamic Therapy Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
13.2.1. Drugs
13.2.1.1. Porphyrin Derivative (PD)
13.2.1.1.1. Hematoporphyrin Derivative (HpD)
13.2.1.1.2. Benzoporphyrin Derivative (BPD)
13.2.1.1.3. Texaphyrins
13.2.1.1.4. Others
13.2.1.2. Aminolevulinic Acid (ALA)
13.2.1.3. Chlorines
13.2.1.4. Others
13.2.2. Devices
13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
13.2.2.2. Diode Laser
13.3. Latin America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
13.3.1. Cancer
13.3.1.1. Basal Cell Carcinoma
13.3.1.2. Non-small Cell Lung Cancer
13.3.1.3. Head & Neck Cancer
13.3.1.4. Others
13.3.2. Actinic Keratosis (AK)
13.3.3. Psoriasis
13.3.4. Acne
13.3.5. Others
13.4. Latin America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Cosmetics & Dermatology Clinics
13.4.3. Cancer Treatment Centers
13.4.4. Others
13.5. Latin America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Photodynamic Therapy Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
14.2.1. Drugs
14.2.1.1. Porphyrin Derivative (PD)
14.2.1.1.1. Hematoporphyrin Derivative (HpD)
14.2.1.1.2. Benzoporphyrin Derivative (BPD)
14.2.1.1.3. Texaphyrins
14.2.1.1.4. Others
14.2.1.2. Aminolevulinic Acid (ALA)
14.2.1.3. Chlorines
14.2.1.4. Others
14.2.2. Devices
14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
14.2.2.2. Diode Laser
14.3. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
14.3.1. Cancer
14.3.1.1. Basal Cell Carcinoma
14.3.1.2. Non-small Cell Lung Cancer
14.3.1.3. Head & Neck Cancer
14.3.1.4. Others
14.3.2. Actinic Keratosis (AK)
14.3.3. Psoriasis
14.3.4. Acne
14.3.5. Others
14.4. Middle East & Africa Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Cosmetics & Dermatology Clinics
14.4.3. Cancer Treatment Centers
14.4.4. Others
14.5. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Photodynamic Therapy Market Share Analysis, by Company (2018)
15.2. Company Profiles
15.2.1. Biofrontera AG
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Theralase Technologies Inc.
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. Financial Overview
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. LUMIBIRD
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. SWOT Analysis
15.2.4. Quest PharmaTech Inc.
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Modulight, Inc.
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Galderma Laboratories L.P. (Nestlé)
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Sun Pharmaceutical Industries Ltd.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. Financial Overview
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. SUS Advancing Technology Co., Ltd
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. SWOT Analysis
List of TablesTable 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drug, 2017–2027
Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027